Molecular mechanisms of prostate cancerPORKKA, Kati P; VISAKORPI, Tapio.European urology. 2004, Vol 45, Num 6, pp 683-691, issn 0302-2838, 9 p.Article

Cloning and characterization of a novel six-transmembrane protein STEAP2, expressed in normal and malignant prostatePORKKA, Kati P; HELENIUS, Merja A; VISAKORPI, Tapio et al.Laboratory investigation. 2002, Vol 82, Num 11, pp 1573-1582, issn 0023-6837, 10 p.Article

Endometrial K-ras mutations in postmenopausal breast cancer patients treated with adjuvant tamoxifen or toremifeneWALLEN, Mika; TOMAS, Eija; VISAKORPI, Tapio et al.Cancer chemotherapy and pharmacology. 2005, Vol 55, Num 4, pp 343-346, issn 0344-5704, 4 p.Article

Alterations of androgen receptor in prostate cancerLINJA, Marika J; VISAKORPI, Tapio.Journal of steroid biochemistry and molecular biology. 2004, Vol 92, Num 4, pp 255-264, issn 0960-0760, 10 p.Article

Amplification of the urokinase gene and the sensitivity of prostate cancer cells to urokinase inhibitorsHELENIUS, Merja A; SAVINAINEN, Kimmo J; BOVA, G. Steven et al.BJU international (Papier). 2006, Vol 97, Num 2, pp 404-409, issn 1464-4096, 6 p.Article

Amplification of hypoxia-inducible factor 1α gene in prostate cancerSARAMÄKI, Outi R; SAVINAINEN, Kimmo J; NUPPONEN, Nina N et al.Cancer genetics and cytogenetics. 2001, Vol 128, Num 1, pp 31-34, issn 0165-4608Conference Paper

Androgen receptor modifications in prostate cancer cells upon long-term androgen ablation and antiandrogen treatmentMARQUES, Rute B; ERKENS-SCHULZE, Sigrun; DE RIDDER, Corrina M et al.International journal of cancer. 2005, Vol 117, Num 2, pp 221-229, issn 0020-7136, 9 p.Article

Expression of androgen receptor coregulators in prostate cancerLINJA, Marika J; PORKKA, Kati P; KANG, Zhikang et al.Clinical cancer research. 2004, Vol 10, Num 3, pp 1032-1040, issn 1078-0432, 9 p.Article

PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancerRUOXIANG WANG; JIANCHUN XU; DONG, Jin-Tang et al.Cancer research (Baltimore). 2004, Vol 64, Num 5, pp 1589-1594, issn 0008-5472, 6 p.Article

Increased Expression of Androgen Receptor Sensitizes Prostate Cancer Cells to Low Levels of AndrogensWALTERING, Kati K; HELENIUS, Merja A; SAHU, Biswajyoti et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 20, pp 8141-8149, issn 0008-5472, 9 p.Article

TMPRSS2:ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable PrognosisSARAMÄKI, Outi R; HARJULA, Anna E; MARTIKAINEN, Paula M et al.Clinical cancer research. 2008, Vol 14, Num 11, pp 3395-3400, issn 1078-0432, 6 p.Article

Human pHyde is not a classical tumor suppressor gene in prostate cancerPORKKA, Kati P; NUPPONEN, Nina N; TAMMELA, Teuvo L. J et al.International journal of cancer. 2003, Vol 106, Num 5, pp 729-735, issn 0020-7136, 7 p.Article

Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancerLINJA, Marika J; SAVINAINEN, Kimmo J; SARAMÄKI, Outi R et al.Cancer research (Baltimore). 2001, Vol 61, Num 9, pp 3550-3555, issn 0008-5472Conference Paper

USP22 Regulates Oncogenic Signaling Pathways to Drive Lethal Cancer ProgressionSCHRECENGOST, Randy S; DEAN, Jeffry L; VISAKORPI, Tapio et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 1, pp 272-286, issn 0008-5472, 15 p.Article

Loss of PTEN Is Associated with Aggressive Behavior in ERG-Positive Prostate CancerLEINONEN, Katri A; SARAMÄKI, Outi R; TOLONEN, Teemu T et al.Cancer epidemiology, biomarkers & prevention. 2013, Vol 22, Num 12, pp 2333-2344, issn 1055-9965, 12 p.Article

Histopathological variables and biomarkers enhancer of zeste homologue 2, Ki-67 and minichromosome maintenance protein 7 as prognosticators in primarily endocrine-treated prostate cancerTOLONEN, Teemu T; TAMMELA, Teuvo L. J; KUJALA, Paula M et al.BJU international (Papier). 2011, Vol 108, Num 9, pp 1430-1438, issn 1464-4096, 9 p.Article

TCEB1 promotes invasion of prostate cancer cellsJALAVA, Sanni E; PORKKA, Kati P; RAUHALA, Hanna E et al.International journal of cancer (Print). 2009, Vol 124, Num 1, pp 95-102, issn 0020-7136, 8 p.Article

CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locusBERNARD, David; MARTINEZ-LEAL, Juan F; RIZZO, Sian et al.Oncogene (Basingstoke). 2005, Vol 24, Num 36, pp 5543-5551, issn 0950-9232, 9 p.Article

Amplification of urokinase gene in prostate cancerHELENIUS, Merja A; SARAMÄKI, Outi R; LINJA, Marika J et al.Cancer research (Baltimore). 2001, Vol 61, Num 14, pp 5340-5344, issn 0008-5472Article

Hypermethylation of the GABRE∼miR-452∼miR-224 Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical ProstatectomyKRISTENSEN, Helle; HALDRUP, Christa; VISAKORPI, Tapio et al.Clinical cancer research (Print). 2014, Vol 20, Num 8, pp 2169-2181, issn 1078-0432, 13 p.Article

Chemical castration and anti-androgens induce differential gene expression in prostate cancerLEHMUSVAARA, Saara; ERKKILÄ, Timo; KAIPIA, Antti et al.Journal of pathology (Print). 2012, Vol 227, Num 3, pp 336-345, issn 0022-3417, 10 p.Article

Androgen Regulation of micro-RNAs in Prostate CancerWALTERING, Kati K; PORKKA, Kati P; JALAVA, Sanni E et al.The Prostate. 2011, Vol 71, Num 6, pp 604-614, issn 0270-4137, 11 p.Article

Transcription Factor Stat5 Synergizes with Androgen Receptor in Prostate Cancer CellsTAN, Shyh-Han; DAGVADORJ, Ayush; VISAKORPI, Tapio et al.Cancer research (Baltimore). 2008, Vol 68, Num 1, pp 236-248, issn 0008-5472, 13 p.Article

DNA Methylation Signatures for Prediction of Biochemical Recurrence After Radical Prostatectomy of Clinically Localized Prostate CancerHALDRUP, Christa; MUNDBJERG, Kamilla; ØRNTOFT, Torben F et al.Journal of clinical oncology. 2013, Vol 31, Num 26, pp 3250-3258, issn 0732-183X, 9 p.Article

The Mutational Landscape of Prostate CancerBARBIERI, Christopher E; BANGMA, Chris H; BJARTELL, Anders et al.European urology. 2013, Vol 64, Num 4, pp 567-576, issn 0302-2838, 10 p.Article